Characterization of Wiskott-Aldrich syndrome (WAS) mutants using Saccharomyces cerevisiae
about
Effector triggered manipulation of host immune response elicited by different pathotypes of Escherichia coliStoichiometry of Nck-dependent actin polymerization in living cellsUbiquitylation-dependent negative regulation of WASp is essential for actin cytoskeleton dynamicsA peptide derived from the Wiskott-Aldrich syndrome (WAS) protein-interacting protein (WIP) restores WAS protein level and actin cytoskeleton reorganization in lymphocytes from patients with WAS mutations that disrupt WIP bindingX-linked thrombocytopenia causing mutations in WASP (L46P and A47D) impair T cell chemotaxis.Wiskott-Aldrich syndrome/X-linked thrombocytopenia in China: Clinical characteristic and genotype-phenotype correlation.Effector triggered immunityWiskott-Aldrich syndrome protein--dynamic regulation of actin homeostasis: from activation through function and signal termination in T lymphocytes.Evolutionary rescue by compensatory mutations is constrained by genomic and environmental backgrounds.Triple-color FRET analysis reveals conformational changes in the WIP-WASp actin-regulating complex.
P2860
Q26991857-D1F15BAF-9475-4557-9CF9-6981EA9730FEQ30010097-CBADB1F9-32A1-4CE6-AE90-8ACB3103CBB1Q30524705-E2D9A23A-7E4E-4C3B-A56E-BECF56863543Q33394391-A73FFD66-E078-4ED6-9D5A-4B6C7A8C303CQ33417562-FF7F742C-20D0-4999-BD5B-F84D4BF5BD40Q33422471-37376046-4E57-4941-A63B-96D2D565CDAFQ34454097-E8DEF49E-546E-450D-B975-EBED49F19009Q38151844-83CD3F1E-064C-4208-94E9-E5F4AD1640E1Q42098689-448D0C99-65A1-4F25-8361-E01AC0964CA0Q54342392-71B0BDB8-49BA-4FD6-9C37-39B7B25C06B9
P2860
Characterization of Wiskott-Aldrich syndrome (WAS) mutants using Saccharomyces cerevisiae
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Characterization of Wiskott-Aldrich syndrome (WAS) mutants using Saccharomyces cerevisiae
@ast
Characterization of Wiskott-Aldrich syndrome (WAS) mutants using Saccharomyces cerevisiae
@en
Characterization of Wiskott-Aldrich syndrome (WAS) mutants using Saccharomyces cerevisiae
@nl
type
label
Characterization of Wiskott-Aldrich syndrome (WAS) mutants using Saccharomyces cerevisiae
@ast
Characterization of Wiskott-Aldrich syndrome (WAS) mutants using Saccharomyces cerevisiae
@en
Characterization of Wiskott-Aldrich syndrome (WAS) mutants using Saccharomyces cerevisiae
@nl
prefLabel
Characterization of Wiskott-Aldrich syndrome (WAS) mutants using Saccharomyces cerevisiae
@ast
Characterization of Wiskott-Aldrich syndrome (WAS) mutants using Saccharomyces cerevisiae
@en
Characterization of Wiskott-Aldrich syndrome (WAS) mutants using Saccharomyces cerevisiae
@nl
P2093
P1433
P1476
Characterization of Wiskott-Aldrich syndrome (WAS) mutants using Saccharomyces cerevisiae
@en
P2093
Arshad Raodah
Ming Hwa Wong
Rajamuthiah Rajmohan
P304
P356
10.1111/J.1567-1364.2009.00581.X
P407
P577
2009-12-01T00:00:00Z